The Australian market today presents a mixed outlook, with the Aussie dollar inching closer to 67 cents against the USD and ...
When she died of breast cancer aged only 43, amateur athlete and fundraiser Jane Tomlinson left a number of incredible ...
Zoe Wilson thought she may be at risk. It wasn’t just a vague gut feeling: the risk was demonstrable and clear, running ...
Leading genomic health experts from Monash University are calling for urgent government funding to progress the development ...
Today, the Nature Health journal has published Monash University’s DNA Screen study results. The study piloted the idea of ...
AOA Dx debuted Follow the Exits at JPM 2026, analyzing 25 years of women’s health exits—$100B+ in value—proving a ...
GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative ...
GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE(R) natural killer (NK ...
GT Biopharma targets a portion of the estimated $362 billion global solid tumor market Preliminary, unaudited cash balance of approximately $7 million as of December 31, 2025 anticipated to extend cas ...
A Philadelphia Court of Common Pleas jury is slated to hear opening arguments on Tuesday in a case claiming that a ...
Woman's World on MSN
Can the New At-Home HPV Test, Teal Wand, Really Replace Pap Smears?
If you've been putting off scheduling your Pap smear—maybe for months, maybe longer—take a deep breath. There's no judgment ...
Next-generation cancer tests are being developed here in Houston, and the HBJ pulled back the curtain on how one partnership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback